Pfizer Must Face Suit on Rezulin, Court Says
From Bloomberg News
Pfizer Inc. must face a class-action suit in West Virginia over its Rezulin diabetes drug’s role in destroying some patients’ livers, a state appeals court ruled.
The West Virginia Supreme Court reversed a lower court ruling denying 5,000 former Rezulin users the right to join together to sue the drug maker over the costs of monitoring their health in the future.
Pfizer’s shares fell 9 cents to $34.31 on the NYSE.
